Maximus (NYSE:MMS) Posts Quarterly Earnings Results, Beats Expectations By $0.22 EPS

Maximus (NYSE:MMSGet Free Report) announced its quarterly earnings data on Thursday. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22, Zacks reports. Maximus had a return on equity of 20.95% and a net margin of 5.78%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.

Maximus Price Performance

MMS traded down $0.91 on Friday, hitting $69.09. 424,338 shares of the company’s stock traded hands, compared to its average volume of 690,485. The company’s 50 day simple moving average is $74.83 and its 200-day simple moving average is $83.53. The firm has a market cap of $3.95 billion, a price-to-earnings ratio of 13.84 and a beta of 0.72. Maximus has a one year low of $68.30 and a one year high of $93.97. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.74%. Maximus’s payout ratio is 24.00%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on MMS. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Thursday.

Get Our Latest Report on Maximus

Insider Buying and Selling at Maximus

In other Maximus news, Director Raymond B. Ruddy purchased 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average price of $71.46 per share, with a total value of $249,395.40. Following the acquisition, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. This trade represents a 3.20 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Bruce Caswell purchased 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average cost of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders bought 7,063 shares of company stock worth $502,017 in the last quarter. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Earnings History for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.